Tyrosine

Tyrosine

SCHEMBL6135474

CC(C)[C@H](N)C(=O)OC(=O)[C@@H](N)COC(=O)[C@@H](N)[C@@H](C)OC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 3/20 0.50
MAPT P10636 3/20 0.50
LMNA P02545 2/20 0.50
TSHR P16473 2/20 0.50
BLM P54132 2/20 0.50
PMP22 Q01453 2/20 0.50
MEN1 O00255 2/20 0.50
MPO P05164 1/20 0.50
HIF1A Q16665 1/20 0.50
TACR1 P25103 2/20 0.46
OPRM1 P35372 2/20 0.45
OPRD1 P41143 2/20 0.45
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43
HTR2A P28223 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tyrosine SCHEMBL1833539 0.95 KMT2A (0.55) KMT2AKDM4EMAPTLMNATSHR
SCHEMBL9397484 0.91 KMT2A (0.47) KMT2AKDM4EMAPTLMNATSHR
Tyrosine SCHEMBL5605978 0.88 KMT2A (0.60) KMT2AKDM4EMAPTLMNATSHR
SCHEMBL9225869 0.85 KDM4E (0.52) KMT2AKDM4EMAPTLMNATSHR
SCHEMBL7356307 0.85 KDM4E (0.63) KMT2AKDM4EMAPTLMNATSHR
Tyrosine SCHEMBL9449484 0.84 KDM4E (0.63) KMT2AKDM4EMAPTLMNATSHR
SCHEMBL8366913 0.84 KDM4E (0.51) KMT2AKDM4EMAPTLMNATSHR
Tyrosine SCHEMBL1065122 0.84 KMT2A (0.68) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL27895091 0.82 KDM4E (0.68) KMT2AKDM4EMAPTLMNATSHR
Phenylalanine SCHEMBL9668359 0.81 MEN1 (0.39) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594819-A1 IRREVERSIBLE CASPASE-3 INHIBITORS AS ACTIVE SITE PROBES Merck Frosst Canada & Co. (CA) 2005-11-16 EP disclosed
WO-2004069773-A1 IRREVERSIBLE CASPASE-3 INHIBITORS AS ACTIVE SITE PROBES MERCK FROSST CANADA LTD. (CA) 2004-08-19 WO disclosed